Open AccessPeer ReviewedPublished Monthly Since 2007 Vol. 19, Issue 12 · November 2026Media Kitinfo@guident.net

Dental Management of Cardiovascular Compromised Patients- a Review

  • Dr. Hannah MaryamIntern
  • Dr. Prasanna Kumar RaoProfessor

Department of Oral and Maxillofacial Surgery, Department of Oral Medicine & Radiology, A.J Institute of Dental Sciences, Kuntikana, Mangaluru

Guident · Volume 14, Issue 9 (August 2021)Published August 20216 min read

ABSTRACT

Cardiovascular diseases are group of diseases that affects the heart and blood vessels. This article presents various dental considerations towards treating cardiovascular patients. Many patients suffering from cardiovascular diseases present to a General Dentist for dental checkups and treatments. Thus a dentist must have full understanding of the implications of the disease so that an efficient and safe treatment could be provided.

The goal of this review article is to highlight strategies for managing and preventing complications during dental treatment.

Keywords: Cardiovascular diseases, Complications, Risk, Dental management

INTRODUCTION

Cardiovascular disease is a leading cause of death worldwide. This disease is caused as a result of impairment of the endothelial function followed by inflammation of the vessel wall leading to myocardial infarction and stroke. Heart failures are a result of large myocardial infarction or a result of genetic predisposition or infectious disease.1 According to the World Health Organization, death due to cardiovascular diseases is estimated to 17.9 million lives each year.

Providing dental care for patients with existing valvular heart disease has three major concerns. This includes:

  • Risk of infective endocarditis
  • Risk of exacerbation of existing heart conditions
  • Risk of bleeding in anticoagulated patients2

MANAGEMENT OF INFECTIVE ENDOCARDITIS

Infective endocarditis is a life threatening condition that usually affects the mural, septal and valvular endocardium. This is caused by organisms such as bacteria and fungi. They result in infection which is destructive or subacute infection. Most Patients with infective endocarditis present with preexisting valvular disease.2 Streptococcus viridans is believed to be the most common cause for Infective endocarditis.

Dental Management:

Try to maintain oral hygiene in order to prevent bacterial seeding.

Antibiotic Prophylaxis is recommended when dental procedures involve active bleeding of tissues.3

High risk individuals are those with history of endocarditis, who have prosthetic heart valves, congenital heart disease, systemic pulmonary shunts that are surgically constructed.4

Recommendation of Endocarditis Prophylaxis:

  • High and moderate risk cardiac patients
  • Prophylactic Scaling where bleeding is anticipated
  • Dental Extractions
  • Periodontal Procedures
  • Placement of implant
  • Endodontic treatments
  • Placement of antibiotic fibers or strips sub-gingivally
  • Local anesthetics involving intra ligaments

CASES WHERE ENDOCARDITIS PROPHYLAXIS IS NOT RECOMMENDED

  • Restorative procedures
  • Replacing missing teeth
  • Non intra ligamentary Local anesthetic injections
  • Rubber dam placement
  • Suture removal
  • Fluoride treatments
  • Record Radiographs
  • Shedding of primary teeth
  • Removable prosthodontic or orthodontic appliances placement.
  • Recording of oral impressions4

For effective prophylaxis, antimicrobial prophylaxis is administered within 2 hours following procedure.

  • General prophylaxis

Amoxicillin (Adults) 2.0 g; (Children) 50 mg/kga orally

  • 1 h before procedure
    • Unable to take medications

Ampicillin (Adults) 2.0 g intramuscularly or intravenously; (Children) 50 mg/kga intramuscularly or intravenously

  • within 30 min before procedure
    • Penicillin allergy

Clindamycin (Adults) 600 mg; (Children) 20 mg/kga

  • Orally 1 h before procedure
    • Allergic to penicillin and unable to take oral medications

Clindamycin (Adults) 600 mg (Children) 20 mg/kga

  • Intravenously within 30 min before procedure

Cefazolinb (Adults) 1.0 g; (Children) 25 mg/kga

  • Intramuscularly or intravenously within 30 min before procedure4

MANAGEMENT OF HYPERTENSION

Hypertension refers to elevated blood pressure that exceeds 140 over 90mm Hg with systolic above 140mm Hg and diastolic over 90mm Hg.

Untreated hypertension poses risk to heart, brain, kidney and other diseases. According to the World Health Organization, Hypertension is the major cause of premature death in the world with 1 in every 4 men and 1 in every 4 women in a billion with the condition.

Classification of Hypertension:

  • Normal Blood Pressure - SBP <120 mmHg and DBP <80 mmHg
  • Prehypertension - SBP 120–139 mmHg and DBP 80–89 mmHg
  • Stage I Hypertension-SBP 140–159 mmHg or DBP 90–99 mmHg
  • Stage II Hypertension-SBP ≥160 mmHg or DBP ≥100 mmHg
  • Hypertensive Crisis (with or without end organ damage) - >180/120 mmHg5

Dental Management:

  • Always take thorough history of the patient before starting any treatment.
  • Eliminate pain and minimize anxiety.
  • Pharmacological agents like amphetamine, monoamine oxidase inhibitors, cocaine can result in hyper adrenergic state. These must be documented and dis continued.
  • Hypertensive crisis may be induced with the usage of Epinephrine, and monoamine oxidase inhibitors.
  • Usage of combination of Beta- Blockers and epinephrine may result in reflex Bradycardia and Hypertension.
  • In cases of bleeding due to raised blood pressure, it is recommended to use local anesthesia with vasoconstrictors, oxidized cellulose, ferric sulfate aluminum potassium sulfate, zinc chloride and use cordless retraction techniques during procedures.5

MANAGEMENT OF CARDIAC ARRHYTHMIAS

Arrhythmias refer to abnormal heart rate, origin of impulse or regularity.

Dental Management:

  1. Use anxiolytics to reduce stress and anxiety.
  2. Access vitals and provide oxygen if arrhythmias occurs during treatment
  3. Sub lingual Nitrate is administered if there is sign of chest pain.
  4. Place the patient in Trendelenburg position.

PATIENTS ON ANTICOAGULANT THERAPY:

Cardiovascular diseases poses risk of thrombotic events. Thus anticoagulant drugs are recommended to prevent thrombotic events in cardiovascular cases which includes prevention of Stroke in atrial fibrillation and Acute Coronary Syndrome prevention and treatment.

Unfractionated heparin, Low molecular weight Heparins and Fondaparinux are used as parenteral anticoagulants currently.6

Dental Management:

  • In cases where the patient is on short term anticoagulant therapy, it is best to delay dental treatment until the end of the therapy.
  • If the patient is on aspirin and other anti-platelet agents, this may result in prolonged bleeding during surgery.7
  • Patients taking warfarin should not be prescribed non-selective
  • Following a dental surgery, avoid prescribing NSAIDs and COX-2 inhibitors as analgesics.
  • Warfarin tends to interact with other drugs that may result in derangement of anticoagulant treatment.3

MANAGEMENT OF HEART FAILURE

Heart failure refers to chronic, progressive condition where the heart is unable to pump blood enough to meet the blood and oxygen needs of the body. Heart failure is often the end stage of other heart conditions like ischemic heart disease and Hypertension (arterial)

Dental Management:

  • Consult with physician to know about the medications prescribed and to know degree of hypertension. Controlled hypertensive patients do not pose risk to treatment.
  • Instruct the patients to take medications as usual.
  • Record blood pressure prior procedure, if the values are high, recall the patient when it’s in control.
  • Prescribe anxiolytics in patients who are anxious.
  • Avoid Sudden changes in position of the patient as this can lead to orthostatic hypotension
  • Avoid prescribing NSAIDS longer than 5 days as it can interact with anti-hypertensive drugs, reducing the efficiency of action.8

CONCLUSION

Patients with Cardiovascular diseases are frequently encountered by dental practitioners and treating them requires a dentist to understand potential adverse effects of drugs and also the management of emergencies.

When treating patients, it is important to implement our knowledge to maintain the best quality of care. Thus, thorough knowledge of the disease and approach to patient can result in safe and effective dental treatment.

REFERENCES

  1. Dimmeler S. Cardiovascular disease review series. EMBO molecular medicine. 2011 Dec 1; 3(12):697-.
  2. Warburton G, Caccamese JF. Valvular heart disease and heart failure: dental management considerations. Dental Clinics. 2006 Oct 1; 50(4):493-512.
  3. Singh S, Gupta K, Garg KN, Fuloria NK, Fuloria S, Jain T. Dental management of the cardiovascular compromised patient: a clinical approach. Journal of Young Pharmacists. 2017 Oct 1;9(4):453.
  4. American Heart Association. Prevention of bacterial endocarditis. The Journal of the American Dental Association. 1972 Dec 1;85(6):1377-9.
  5. Southerland JH, Gill DG, Gangula PR, Halpern LR, Cardona CY, Mouton CP. Dental management in patients with hypertension: challenges and solutions. Clinical, cosmetic and investigational dentistry. 2016;8:111.
  6. De Caterina R. The current role of anticoagulants in cardiovascular medicine. Journal of Cardiovascular Medicine. 2009 Aug 1;10(8):595-604.
  7. Jowett NI, Cabot LB. Patients with cardiac disease: considerations for the dental practitioner. British dental journal. 2000 Sep;189(6):297-302.
  8. Pamplona MC, Soriano YJ, Pérez MG. Dental considerations in patients with heart disease. Journal of Clinical and Experimental Dentistry. 2011;3(2):97-105.

Disclaimer from Guident

The views and opinions expressed in articles published in Guident are solely those of the authors and do not necessarily reflect the views of the editors, the editorial board or the publisher, Ivory India. Guident does not endorse any product, technique or treatment described. Clinical content is intended for qualified dental and medical professionals and is not a substitute for individual clinical judgement. Guident, its editors and the publisher accept no liability for any consequence arising from the use of information published in the journal.

How to cite this article

Dr. Hannah Maryam, Dr. Prasanna Kumar Rao. Dental Management of Cardiovascular Compromised Patients- a Review. Guident. 2021 Aug;14(9). Available from: https://ivoryindia.in/articles/general/dental-management-of-cardiovascular-compromised-patients-a-review.html

Related articles

More in General

All 212 articles
Vol. 14, Issue 9 · August 2021

Cross Contamination and Ways to Avoid It

Cross contamination , also referred as cross infection which implies transfer of bacteria or other contaminants from one surface, substance or subject to another because of unsanitary or…

Dr. Ratnadeep Jadhav

Vol. 14, Issue 9 · August 2021

Bioterrorism

Bioterrorism is a phenomenon of illegal use of biological agents against a civilian population to influence the policy of a government in the pursuit of personal, political, religious…

Dr. Deepak Thakur

Call for papers

Publish your clinical work in Guident

Original research, case reports and review articles are welcomed from clinicians and researchers worldwide. Every submission is assessed by the editorial board.